The HLA-B12 antigen is significantly increased in Caucasian patients with Stevens-Johnson syndrome (SJS) with ocular complications, while HLA-A*0206 is strongly associated with Japanese patients with SJS/toxic epidermal necrolysis (TEN) with ocular complications. There are strong ethnic differences in the association between HLA and SJS/TEN. Regarding the association between HLA and drug-induced severe cutaneous adverse reactions (SCAR), including SJS and TEN, the strong allopurinol-specific association between HLA-B*5801 and allopurinol-induced SCAR may be a universal phenomenon, since it has been identified in all Han Chinese, Caucasian and Japanese patients. In contrast, the carbamazepine-specific association between HLA-B*1502 and carbamazepine-induced SJS may be specific to certain ethnic groups, as it has been identified in Han Chinese but not in Caucasian and Japanese patients. Dermatologists have reported that allopurinol and anticonvulsant drugs such as carbamazepine are commonly associated with SJS/TEN, while many of the author's patients developed SJS after receiving treatment for the common cold with antibiotics, cold remedies and/or non-steroidal antiinflammatory drugs (NSAIDs). This article posits that the SJS/TEN patients seen by dermatologists are not always the same as the SJS/TEN patients consulting opthalmologists.
Stevens and Johnson, both paediatricians, encountered two boys seven and eight years of age who manifested an extraordinary, generalised skin eruption, persistent fever, inflamed buccal mucosa and severe purulent conjunctivitis resulting in severe visual disturbance. They carefully ruled out drug ingestion as a causative factor of the skin eruption. Subsequently, paediatricians reported that SJS was associated with infectious agents such as Mycoplasma pneumoniae 2 and had a viral aetiology involving herpes simplex virus, Epstein-Barr virus, cytomegalovirus and varicella zoster virus. 3 In contrast, dermatologists claimed that more than 100 drugs were involved in eliciting SJS and its severe variant, toxic epidermal necrolysis (TEN). 4 They cited life-threatening severe adverse drug reactions characterised by high fever, rapidly developing blistering exanthema of macules and target-like lesions accompanied by mucosal involvement and skin detachment. 4, 5 Formerly, erythema multiforme (EM), SJS and TEN were accepted as being part of a single EM spectrum; however, a retrospective analysis of the type and distribution of the skin lesions and the extent of epidermal detachment identified EM major and SJS/TEN as two distinct clinical entities that differed with respect to their histopathological changes and aetiology. 6 The annual incidence of SJS and TEN has been estimated as 0.4 to one and one to six cases per million persons, respectively; 6,7 the reported mortality rate is 3 and 27%, respectively. 8 Although rare, these reactions carry high morbidity and mortality rates and often result in severe and definitive sequelae such as vision loss. The pathobiological mechanisms underlying the onset of SJS/TEN have not been fully established. The extreme rarity of cutaneous and ocular surface reactions to drug therapies led us to suspect individual susceptibility.
In the acute stage, SJS/TEN patients manifest severe conjunctivitis and corneal/conjunctival epithelial defects with vesiculobullous skin lesions. In the chronic stage, ocular surface complications such as conjunctival invasion into the cornea due to corneal epithelial stem cell deficiency, symblepharon, ankyloblepharon and, in some instances, keratinisation of the ocular surface persist despite healing of the skin lesions (see Figure 1 ). 9 We documented elsewhere that more than 95% of patients with SJS/TEN with ocular surface complications had lost their fingernails in the acute or subacute stage, and that some continued to have transformed nails even after healing of their skin lesions (see Figure 2) . 10 Our diagnosis of SJS/TEN (SJS in a broad sense) was based on a confirmed history of acute-onset high fever, serious mucocutaneous illness with skin eruptions and involvement of at least two mucosal sites, including the ocular surface. 17 In this study, the onset of SJS with ocular involvement was associated with putative viral syndromes or the administration of drugs.
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The second report involving HLA analysis in SJS was published by the dermatologist Roujeau and colleagues in 1986. 18 Their study of 45 French SJS/TEN patients whose disorder was clearly druginduced showed that the frequency of the HLA-B12 antigen was significantly increased compared with a French control population comprising 66 individuals (57.7 versus 25.7%; p<0.001, pc<0.04).
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The causative agents were non-steroidal anti-inflammatory drugs (NSAIDs) in 25 patients (56%), including 18 who had taken oxicam derivatives, and sulphamides in 14 (31%). 18 The association with HLA-B12 was most pronounced in patients treated with sulphonamide and oxicam NSAIDs. In another study, the same group found that the frequency of the HLA-B12 antigen was significantly increased in 44 surviving French TEN patients compared with a French control population. 19 In 1996, Power et al. 20 We subsequently examined HLA-class I (HLA-A, -B, -C) antigens in 40
Japanese SJS/TEN patients with ocular complications. 13 We found that the carrier frequency of the HLA-A*0206 antigen was significantly higher in these patients compared with 113 Japanese controls (47.5 versus 15.0%; p=0.00003, pc<0.0005; OR 5.1) and that there was a negative association with HLA-A*1101. 13 Furthermore, we studied HLA class I and II (DRB1 and DQB1) gene polymorphisms in 71 Japanese patients with SJS/TEN with ocular complications. 16 Again, we found that HLA-A*0206 was strongly associated with SJS/TEN with ocular complications; there was no association with HLA-DQB1*0601. 16 The onset of SJS with ocular complications was associated with putative viral syndromes or the administration of drugs, 13, 16 a finding that coincided with that of Mondino. 17 Although the HLA-B12 antigen was significantly increased in Caucasian SJS patients, [17] [18] [19] we found no association with HLA-B12 in Japanese Thus, our findings suggest strong ethnic differences in the association of SJS/TEN with HLA (see Table 1 ). Because SJS/TEN is rare and probably has a complex genetic inheritance background, specific combinations of genes and certain environmental factors may be required for the manifestation of this rare phenotype.
Drugs and Human Leukocyte Antigen
The association between HLA and drug-induced severe cutaneous adverse reactions including SJS and TEN has been reported. The HLA-B*1502 allele showed a very strong association with carbamazepineinduced SJS/TEN in the Han Chinese of Taiwan. 22 In that study, dermatologists examined 44 patients with carbamazepine-induced SJS. They found that the frequency of HLA-B*1502 was significantly increased compared with a carbamazepine-tolerant control group of 101 individuals (100 versus 3%; pc=3.13x10 -27 ; OR 2504) and a control population consisting of 93 normal subjects (8.6%; pc=1.38x10 -21 ; OR 895). 22 In supplemental data, they showed that 28 of the 44 patients (63.6%) manifested ocular surface erosion. 22 In contrast, no such strong carbamazepine-specific association between HLA-B*1502 and carbamazepine-induced SJS/TEN was found in Caucasian patients. 23, 24 In our study of 71 Japanese SJS/TEN patients with ocular complications and 113 Japanese controls, we did not detect HLA-B*1502 in either group 16 because the allele frequency of HLA-B*1502 is very low in Japanese individuals. We suggest that the carbamazepine-specific association between HLA and carbamazepine-induced SJS may also be specific to certain ethnic groups (see Table 2 ).
Another Taiwanese study showed that HLA-B*5801 was present in all Han Chinese with allopurinol-induced SJS/TEN and drug-induced hypersensitivity (DIHS). 25 Table 2 ).
Discussion
American ophthalmologists 17 and French dermatologists 18 have documented that the HLA-B12 (HLA-Bw44) antigen was significantly increased in Caucasian SJS patients. However, in our Japanese study population there was no association with HLA-B12, probably because in Caucasians the HLA-B12 antigen is primarily coded by HLA-B*4402, whereas in the Japanese it is almost exclusively coded by HLA-B*4403. 21 In contrast, while HLA-A*0206 was strongly associated with SJS/TEN with ocular complications in Japanese patients, 13, 16 it is absent in Caucasian populations. Thus, HLA-A*0206 may be related to Japanese ethnicity. These findings suggest strong ethnic differences in the HLA-SJS/TEN association and point to the need for studies in other ethnic populations to obtain a global picture.
With respect to the association between HLA and drug-induced severe cutaneous adverse reactions (SCAR), including SJS and TEN, the association between the HLA-B*1502 allele and carbamazepineinduced SJS/TEN 22, 24 and between the HLA-B*5801 allele and allopurinol-induced severe cutaneous adverse reactions 23, 25 has been reported.
In Han Chinese 22 but not in Caucasian patients, 23, 24 there was a strong carbamazepine-specific association between HLA-B*1502
and carbamazepine-induced SJS/TEN. We did not identify HLA-B*1502 in either our Japanese SJS/TEN patients or our controls, 13, 16 because the allele frequency of HLA-B*1502 is very low in the Japanese. Thus, the carbamazepine-specific association between HLA and carbamazepine-induced SJS may be specific to certain ethnic groups.
An allopurinol-specific association between HLA-B*5801 and allopurinol-induced SCAR was identified in all Han Chinese, 25 28 we evaluated the possibility of an association between SJS/TEN and a disordered innate immune response. 10, 11 We postulated that viral infection and/or drugs may trigger a disorder in the host's innate immune response and that this event is followed by aggravated inflammation of the mucous membranes, ocular surface and skin. We also documented that in Japanese SJS/TEN patients with ocular complications there was an association with TLR3-10 and IL4R polymorphisms. 11 Thus, not only genetic factors related to HLA but also innate immunity play important roles in the integrated aetiology of SJS/TEN.
A group of dermatologists reported that allopurinol, uric-acidlowering drugs (17.4%) and anticonvulsant drugs such as carbamazepine (8.2%), nevirapine (5.5%), phenobarbital (5.3%), phenytoin (5.0%) and lamotrigine (3.7%) were commonly associated with SJS or TEN and that cotrimoxazole (6.3%), an antibiotic, was also associated. 27 We posit that the SJS/TEN patients seen by dermatologists are not always the same as the SJS/TEN patients consulting opthalmologists. n
